Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 1
2010 1
2013 7
2014 2
2015 5
2016 5
2017 4
2018 3
2019 2
2020 3
2021 4
2022 4
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
MYC dysregulation in the progression of multiple myeloma.
Misund K, Keane N, Stein CK, Asmann YW, Day G, Welsh S, Van Wier SA, Riggs DL, Ahmann G, Chesi M, Viswanatha DS, Kumar SK, Dispenzieri A, Gonzalez-Calle V, Kyle RA, O'Dwyer M, Rajkumar SV, Kortüm KM, Keats JJ; MMRF CoMMpass Network; Fonseca R, Stewart AK, Kuehl WM, Braggio E, Bergsagel PL. Misund K, et al. Leukemia. 2020 Jan;34(1):322-326. doi: 10.1038/s41375-019-0543-4. Epub 2019 Aug 22. Leukemia. 2020. PMID: 31439946 Free PMC article. No abstract available.
Monoclonal immunoglobulins promote bone loss in multiple myeloma.
Westhrin M, Kovcic V, Zhang Z, Moen SH, Nedal TMV, Bondt A, Holst S, Misund K, Buene G, Sundan A, Waage A, Slørdahl TS, Wuhrer M, Standal T. Westhrin M, et al. Among authors: misund k. Blood. 2020 Dec 3;136(23):2656-2666. doi: 10.1182/blood.2020006045. Blood. 2020. PMID: 32575115 Free article.
Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence.
Misund K, Hofste Op Bruinink D, Coward E, Hoogenboezem RM, Rustad EH, Sanders MA, Rye M, Sponaas AM, van der Holt B, Zweegman S, Hovig E, Meza-Zepeda LA, Sundan A, Myklebost O, Sonneveld P, Waage A. Misund K, et al. Leukemia. 2022 Jul;36(7):1887-1897. doi: 10.1038/s41375-022-01597-y. Epub 2022 May 28. Leukemia. 2022. PMID: 35643867 Free PMC article.
Intracellular IL-32 regulates mitochondrial metabolism, proliferation, and differentiation of malignant plasma cells.
Aass KR, Mjelle R, Kastnes MH, Tryggestad SS, van den Brink LM, Aass Roseth I, Westhrin M, Zahoor M, Moen SH, Vikene Nedal TM, Buene G, Misund K, Sponaas AM, Ma Q, Sundan A, Groen RW, Slørdahl TS, Waage A, Standal T. Aass KR, et al. Among authors: misund k. iScience. 2021 Dec 13;25(1):103605. doi: 10.1016/j.isci.2021.103605. eCollection 2022 Jan 21. iScience. 2021. PMID: 35005550 Free PMC article.
BMPR2 inhibits activin and BMP signaling via wild-type ALK2.
Olsen OE, Sankar M, Elsaadi S, Hella H, Buene G, Darvekar SR, Misund K, Katagiri T, Knaus P, Holien T. Olsen OE, et al. Among authors: misund k. J Cell Sci. 2018 Jun 11;131(11):jcs213512. doi: 10.1242/jcs.213512. J Cell Sci. 2018. PMID: 29739878
A patient with minimal myeloma treatment who survived for 20 years.
Behsen AD, Vandsemb EN, Slørdahl TS, Hjorth-Hansen H, Quist-Paulsen P, Misund K, Sponaas AM, Waage A. Behsen AD, et al. Among authors: misund k. Haematologica. 2023 Oct 5. doi: 10.3324/haematol.2023.283563. Online ahead of print. Haematologica. 2023. PMID: 37794808 Free article.
42 results